Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap3.62B
Enterprise Value2.99B
P/E Ratio-13.28
PEG Ratio0.12
Price/Sales Ratio5.91
Price/Book Ratio1.47
Enterprise/Revenue5.45
Enterprise/EBITDA-17.14

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.44
Operating Margin-0.45
AD

Management Effectiveness

Return On Assets-0.09
Return On Equity-0.11

Income Statement

Revenue541.45M
Revenue/Share4.25
Gross Profit230.88M
EBITDA-140.03M
Net Income-231.27M
Diluted EPS-1.77

Balance Sheet

Total Cash423.52M
Total Cash/Share3.31
Total Debt10.71M
Total Debt/Equity0.01
Current Ratio4.17
Book Value Per Share16.76

Price History

52-Week Change-14.78
52-Week High61.76
52-Week Low22.58
Moving Average 50 Days28.95
Moving Average 200 Days31.81

Statistics

Average Volume7.17M
Shares Outstanding130.89M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0
Last Split FactorN/A
Last Split DateN/A
AD